Rechercher des projets européens

Therapeutic antibodies have transformed cancer therapy during the last decade, due to their high selectivity of targeting cancer cells in comparison to standard small molecule chemotherapy. Most recently, the coupling of cellular toxins to therapeutic antibodies has demonstrated an even greater efficacy in the therapy of cancer and the first, highly potent antibody drug conjugate (ADC), Adcetris®, ...

... Achievements: This was a cooperation between two private companies: an Estonian contract research company TBD-Biodiscovery experienced in synthesis of chemicals for pharmaceutical markets, and a Latvian pharma company Grindex with extensive experience in pharmaceutical market and big scale production. Thi ...